BeiGene, Ltd. (ONC)
NASDAQ: ONC · Real-Time Price · USD
255.59
-0.05 (-0.02%)
May 2, 2025, 4:00 PM EDT - Market closed
BeiGene Market Cap
BeiGene has a market cap or net worth of $27.60 billion as of May 2, 2025. Its market cap has increased by 100.19% in one year.
Market Cap
27.60B
Enterprise Value
26.05B
1-Year Change
100.19%
Ranking
Category
Stock Price
$255.59
Market Cap Chart
Since February 3, 2016, BeiGene's market cap has increased from $861.90M to $27.60B, an increase of 3,101.86%. That is a compound annual growth rate of 45.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 27.29B | 38.60% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 739.39B |
| Johnson & Johnson | 375.64B |
| UnitedHealth Group | 364.02B |
| AbbVie | 351.09B |
| Novo Nordisk | 307.48B |
| Abbott Laboratories | 231.09B |
| Novartis AG | 223.50B |
| AstraZeneca | 221.69B |